Medical Educational Grants

Celgene Medical Educational Grants are awarded in support of high quality, independent educational programs and materials, which demonstrate the potential to improve patient care and health outcomes. Each educational grant awarded must adhere to and be compliant with:

• FDA Final Guidance on Industry-Supported Scientific and Educational Activities,
• Office of Inspector General (OIG) Guidelines,
• Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support,
• Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals,
• American Medical Association (AMA) Ethical Guidelines for Gifts to Physicians from Industry, and
• Other relevant guidelines and regulations.

Supported programs must be independent, objective, balanced and scientifically rigorous. Grants cannot be tied, in any way, to past, present, or future prescribing, purchasing or recommending (including formulary recommendations) of any drug. Meals provided to attendees in conjunction with an accredited program should be modest and in a manner conducive to a group educational environment (e.g., buffet).

Celgene will consider grant requests for both accredited and non-accredited continuing education; however, preference will be given to accredited educational programs. Celgene will consider requests to support independent medical education programs and activities in the following areas:

• Hematology: Multiple Myeloma, MDS, Lymphoma
• Solid Tumor: Breast, Lung, Pancreatic, Melanoma
• Inflammation: Psoriatic Arthritis, Psoriasis

To view information about eligibility, budget guidelines, requirements, deadlines, the application process and contact information please click here  NEW.

Patient Advocacy Grants

Guidelines

Celgene Patient Advocacy collaborates with independent patient organizations that support and advocate on behalf of patients and their families.

The Patient Advocacy Program will consider requests for charitable contributions for activities and initiatives from independent patient organizations. Requests must be consistent with Celgene’s mission and focus areas.

To view information about eligibility, submission guidelines, requirements, deadlines and the application process, please click here [Link to FAQ]. Grant applications must be submitted 60 days prior to the start date of your program/event. Applications submitted less than that timeframe will not be considered for review.

Grant Application Information

Applications for a post Congress activity must be submitted 60 days prior to the start date of the Congress in order to be reviewed by the grant committee. For example:

• Deadline to submit for a post ASH activity is October 6, 2013
• Deadline to submit for a post SABCS activity is October 10, 2013

Applications submitted after the deadline will not be considered for review.

Please note: Grant applications must now be submitted at least 60 days prior to the start date of your program! Applications submitted less than that timeframe will not be considered for review.